SS-31 (Elamipretide): Mitochondrial Membrane Research Overview
How the cardiolipin-binding peptide SS-31 went from a Cornell lab to an FDA-approved drug for Barth syndrome, and what the failed trials along the way showed.
Tagged
1 note in this topic
How the cardiolipin-binding peptide SS-31 went from a Cornell lab to an FDA-approved drug for Barth syndrome, and what the failed trials along the way showed.
All content in the research library is educational and intended for qualified researchers. Products referenced are for laboratory research use only and are not approved for human or veterinary use. Nothing here is medical advice.